UK markets close in 2 hours 53 minutes

ResMed Inc. (RMD)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
197.26+0.93 (+0.47%)
As of 09:37AM EDT. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) 28.88B
Enterprise value 30.06B
Trailing P/E 32.50
Forward P/E 25.38
PEG ratio (5-yr expected) 1.91
Price/sales (ttm)6.43
Price/book (mrq)6.44
Enterprise value/revenue 6.67
Enterprise value/EBITDA 21.02

Trading information

Stock price history

Beta (5Y monthly) 0.65
52-week change 3-9.09%
S&P500 52-week change 329.57%
52-week high 3243.52
52-week low 3132.24
50-day moving average 3185.15
200-day moving average 3175.39

Share statistics

Avg vol (3-month) 3985.13k
Avg vol (10-day) 31.18M
Shares outstanding 5147.09M
Implied shares outstanding 6147.09M
Float 8145.65M
% held by insiders 10.82%
% held by institutions 156.64%
Shares short (15 Mar 2024) 47.66M
Short ratio (15 Mar 2024) 47.58
Short % of float (15 Mar 2024) 45.94%
Short % of shares outstanding (15 Mar 2024) 45.21%
Shares short (prior month 15 Feb 2024) 46.58M

Dividends & splits

Forward annual dividend rate 41.92
Forward annual dividend yield 40.98%
Trailing annual dividend rate 31.84
Trailing annual dividend yield 30.94%
5-year average dividend yield 40.88
Payout ratio 430.46%
Dividend date 314 Mar 2024
Ex-dividend date 407 Feb 2024
Last split factor 22:1
Last split date 331 Aug 2010

Financial highlights

Fiscal year

Fiscal year ends 30 Jun 2021
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 19.77%
Operating margin (ttm)29.18%

Management effectiveness

Return on assets (ttm)11.19%
Return on equity (ttm)21.66%

Income statement

Revenue (ttm)4.5B
Revenue per share (ttm)30.63
Quarterly revenue growth (yoy)12.50%
Gross profit (ttm)N/A
EBITDA 1.37B
Net income avi to common (ttm)890.39M
Diluted EPS (ttm)6.05
Quarterly earnings growth (yoy)-7.20%

Balance sheet

Total cash (mrq)217.86M
Total cash per share (mrq)1.48
Total debt (mrq)1.39B
Total debt/equity (mrq)31.04%
Current ratio (mrq)3.11
Book value per share (mrq)30.47

Cash flow statement

Operating cash flow (ttm)1.08B
Levered free cash flow (ttm)812.89M